Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector

Authors: Bowles, Dawn E, McPhee, Scott WJ, Li, Chengwen, Gray, Steven J, Samulski, Jade J, Camp, Angelique S, Li, Juan, Wang, Bing, Monahan, Paul E, Rabinowitz, Joseph E, Grieger, Joshua C, Govindasamy, Lakshmanan, Agbandje-McKenna, Mavis, Xiao, Xiao, Samulski, R Jude

Source: In Molecular Therapy February 2012 20(2):443-455

Chapter 55 - Novel Approaches for Production of Recombinant Adeno-Associated Virus

Authors: Camp, Angelique S., McPhee, Scott W., Samulski, R. Jude

Source: In Cell Biology Edition: Third Edition. 2006:457-461

904. The Systemic Human Immune Response to Intraparenchymal Administration of AAV

Authors: McPhee, Scott W.J., Janson, Chris G., Li, Chengwen, Samulski, R. Jude, Camp, Angelique S., Francis, Jeremy S., Shera, David, Freese, Andrew, Aita, Anthony L., Goldman, H. Warren, Leone, Paola

Source: In Molecular Therapy 2006 13 Supplement 1:S348-S348

This result is not displayed to guests.
Login for full access.

Recombinant AAV and Corticosteroid Therapy in mdx Mice.

Authors: Shilling, Christopher J., Xiao, Xiao, Samulski, R. Jude, Samulski, Jade, Camp, Angelique S., Mendell, Jerry R.

Source: Neurology; 2006 Supplement, Vol. 66, pA364-A364, 1p